An Overview on Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors Induced Euglycemic Diabetic Ketoacidosis: Clinical Manifestation, Mechanism, Diagnosis, Prevention and Treatment

Euglycemic diabetic ketoacidosis is a transient and  dangerous metabolic condition characterized by ketoacidosis and  considerably lower blood glucose levels which is associated with  the usage of newer class of oral antidiabetic medication known as  Sodium-glucose cotransporter 2 (SGLT-2) inhibitor...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International Journal of Pharma Professional’s Research (IJPPR) 2024-03, Vol.15 (1), p.1-9
Hauptverfasser:	Aakash, R, Prathap, S Aswin, Raj, S Deepak, Dharshne, P T, Priyamalar, E M Neena
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!